On 2025-05-14, Inhibikase Therapeutics, Inc. (IKT) announced earnings per share of $-0.15 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.11.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.10 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.11 | $-0.15 |
| 2024-11-14 | 2024-09-30 | $-0.38 | $-0.65 |
| 2024-08-14 | 2024-06-30 | $-0.58 | $-0.66 |
| 2024-05-15 | 2024-03-31 | $-0.79 | $-0.73 |
| 2024-03-27 | 2023-12-31 | $-0.78 | $-0.63 |
| 2023-11-14 | 2023-09-30 | $-1.12 | $-0.86 |
| 2023-08-14 | 2023-06-30 | $-0.92 | $-1.11 |
| 2023-05-15 | 2023-03-31 | $-0.90 | $-0.96 |
| 2023-03-31 | 2022-12-31 | -- | $-1.02 |
| 2022-11-14 | 2022-09-30 | -- | $-1.08 |
| 2022-08-12 | 2022-06-30 | -- | $-1.08 |
| 2022-05-16 | 2022-03-31 | -- | $-1.08 |
| 2022-03-31 | 2021-12-31 | -- | $-1.20 |
| 2021-11-15 | 2021-09-30 | -- | $-1.08 |
| 2021-08-16 | 2021-06-30 | -- | $-1.32 |
| 2021-05-17 | 2021-03-31 | -- | $-1.56 |
| 2021-04-01 | 2020-12-31 | -- | $-0.90 |